- Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase I/II, observer-blind, randomised, placebo-controlled, multi-country study to evaluate reactogenicity, safety, immune response, and efficacy of an HSV-targeted immunotherapy in healthy participants aged 18-40 years or in participants aged 18-60 years with recurrent genital herpes.
This study is testing a new treatment for herpes simplex (the virus that causes cold sores and genital herpes). It looks at how safe the treatment is, any side effects, and if it helps people with recurrent genital herpes, comparing it to a dummy treatment.
For: Herpes SimplexEstonia · Belgium · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
VItamin C in Thermal injuRY: The VICToRY Trial A phase III multi-center randomized trial
This study, called VICToRY, is looking at whether giving vitamin C to people with severe burns can help their organs work better and reduce the risk of serious problems. Researchers want to see if vitamin C helps people recover faster and get out of hospital sooner.
For: Severely burned patientsBelgium · Germany · France